Netherlands· NL-aec770f2f619
Nevirapine Amarox 400 mg tabletten met verlengde afgifte
A nevirapine product containing nevirapine 0-water, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Nevirapine is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Nevirapine · ATC J05AG01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nevirapine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nevirapine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$7.77
- FR France$3.81
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NEVIRAPINE 0-WATER
- Manufacturer
- Amarox Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- J05AG01
- ATC class
- Nevirapine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id117662
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
316 interactions on record for nevirapine.
Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nevirapine · interactions on record
316 records
- 26 severe
- 220 moderate
- 8 minor
- 49 info
Most severe, free to view
- DeflazacortH02AB13severe
- BrigatinibL01ED04severe
- LorlatinibL01ED05severe
- CobimetinibL01EE02severe
13 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nevirapine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNevirapine 400mg modified-release tabletsDr Reddy's Laboratories (UK) Ltd
- FinlandNevirapine AccordAccord Healthcare B.V.
- FranceNEVIRAPINE ACCORD LP 400 mg, comprimé à libération prolongéeACCORD HEALTHCARE FRANCE
- SpainNEVIRAPINA ACCORD 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGAccord Healthcare S.L.U.
- BelgiumNevirapine Accord 400 mgAccord Healthcare
- NorwayNevirapin mylanMylan
- CzechiaVIRAMUNEBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- SwedenNevirapin Ebb 400 mg DepottablettEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Nevirapin Viatris
- Belgium · Nevirapine Viatris
- Germany · Nevirapin Abdi, Nevirapin Aurobindo
- Denmark · Nevirapine Medical Valley, Nevirapine Viatris
- Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
- Finland · Nevirapine Viatris
- France · Nevirapine Arrow Lab, Nevirapine Cristers
- United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
- Greece · Nevirapine Vocate
- Iceland · Viramune
- Italy · Nevirapina Aurobindo, Nevirapina Mylan
- Liechtenstein · Viramune
- Luxembourg · Nevirapine Viatris
- Norway · Viramune
- Portugal · Nevirapina Accord, Nevirapina Aurovitas
- Romania · Nevirapina Accord, Nevirapină Accord
- Sweden · Nevirapine Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da193324-e9cf-4cca-a0e4-7c2abb7c7855 GET /v1/drugs/da193324-e9cf-4cca-a0e4-7c2abb7c7855?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet met verlengde afgifte",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117662_smpc.pdf",
"strength": null,
"atc_label": "Nevirapine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117662",
"excipients": [
"HYPROMELLOSE 2208 (Release controlling polymer), K4M (E 464)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)"
],
"substances": [
"NEVIRAPINE 0-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117662.pdf",
"authorised_at": "2017/07/10",
"procedure_number": "NL/H/3540/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "117662",
"additional_monitoring": "N"
}See everything about nevirapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.